loadpatents
Patent applications and USPTO patent grants for Jerala-Strukelj; Zdenka.The latest application filed is for "new combination".
Patent | Date |
---|---|
Compositions for treatment of heart failure in dogs Grant 10,874,618 - Grmas , et al. December 29, 2 | 2020-12-29 |
New Combination App 20140363505 - Grmas; Jernej ;   et al. | 2014-12-11 |
Controlled Release Pharmaceutical Compositions Comprising O-desmethyl-venlafaxine App 20120027857 - Abramovic; Zrinka ;   et al. | 2012-02-02 |
Sirolimus formulation Grant 8,053,444 - Reven , et al. November 8, 2 | 2011-11-08 |
Single Dosage Pharmaceutical Formulation Comprising Eprosartan Mesylate App 20110135738 - Legen; Igor ;   et al. | 2011-06-09 |
Tablet Comprising Eprosartan Mesylate App 20110112160 - Legen; Igor ;   et al. | 2011-05-12 |
Pharmaceutical composition comprising eszoplicone App 20080299193 - Jerala-Strukelj; Zdenka ;   et al. | 2008-12-04 |
Pharmaceutical Composition App 20080242725 - Kerc; Janez ;   et al. | 2008-10-02 |
Sirolimus Formulation App 20080176888 - Reven; Sebastjan ;   et al. | 2008-07-24 |
Pharmaceutical Composition Containing Candesartan Cilexetil as Lipophilic Crystalline Substance App 20080118564 - Jerala-Strukelj; Zdenka ;   et al. | 2008-05-22 |
Pharmaceutical Formulation App 20070298108 - Svete; Peter ;   et al. | 2007-12-27 |
Inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrin and a sustained release pharmaceutical preparation containing the same Grant 5,079,237 - Husu , et al. January 7, 1 | 1992-01-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.